The relationship between convalescent plasma therapy for patients recovering from COVID-19 and patients positive for COVID-19

Nastiti Faradilla Ramadhani 1, *, Aga Satria Nurrachman 1, Eha Renwi Astuti 1, Otty Ratna Wahjuni 1, Yunita Savitri 1, Sri Wigati Mardi Mulyani 1, Deny Saputra 1, Ramadhan Hardani Putra 1, Alhidayati Asymal 1, Dwi Siti Lativa 2 and Hana Atsarina Imtinan 2

1 Department of Dentomaxillofacial Radiology,  Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia.
2 Undergraduate Student, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia.
Review Article
World Journal of Advanced Research and Reviews, 2024, 22(03), 172–175
Article DOI: 10.30574/wjarr.2024.22.3.0083
Publication history: 
Received on 23 April 2024 revised on 02 June 2024; accepted on 04 June 2024
The arrival of a pneumonia disease with severe acute respiratory syndrome called COVID-19 has taken the world by storm. It is presence has made researchers and the World Health Organization (WHO) continue to try to find the right clinical management protocol to deal with this pandemic. The use of convalescent plasma, which has been around for a long time, has been discussed recently. Convalescent plasma (CP) therapy is a classic adaptive immunotherapy that has been applied in the prevention and treatment of infectious diseases for more than a century and has been used previously in the improvement of survival in patients with SARS and many studies have shown significant improvement in the condition of patients after administration of convalescent plasm.a As virological and clinical characteristics have similarities between SARS, Middle East Respiratory Syndrome (MERS), and COVID-19, CP therapy may be a promising treatment option for COVID-19 rescue.
Convalescent plasma; COVID-19; Immunotherapy; Infectious diseases
Full text article in PDF: 
Share this